Buy & Hold This “Essential” Dividend Stock Long-Term

Whether you’re in retirement or not, generating reliable income on your investments can help you navigate even the toughest market cycles.

That’s why I want to bring you one reliable dividend stock to own for the long-term.

It’s an essential business with nearly 10,000 locations that are continuing to operate even amid the coronavirus outbreak.

And with a dividend yield 5.3X higher than the 10-year U.S. Treasury, it can help you weather the ups and downs of the unpredictable market we find ourselves in today.

Here it is…

CVS Health Corp (NYSE: CVS)

finviz dynamic chart for  CVS

You know CVS. Surely, you’ve been to one or more of their 9,967 retail pharmacy locations at one point or another.

But in case you’re unaware, CVS Health Corp. (NYSE: CVS) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain, CVS Caremark, a pharmacy benefits manager, Aetna, a health insurance provider, and many other brands.

A lot of investors forget CVS bought Aetna (the nation’s third-largest health insurer at the time) for $69 billion back in 2018… But that’s what gives it a huge advantage over its main competitors, Walgreens and Rite Aid.

You see, about 40 million people rely on Aetna to help them make decisions about their health care and their health care spending.

So, CVS is becoming the preferred pharmacy of choice for these customers because it’s reducing the cost of providing care to Aetna’s customers.

CVS is able to do that and still remain profitable because it doesn’t have to spend as much money acquiring new customers now that it owns Aetna.

And the health information CVS gains from Aetna allows it to better services its 75 million plan members who rely on the pharmacy for their prescription drugs.

CVS stock took a hit with the broader market back in March, falling 32.5%. Since then, it has rallied 21%, but I still think the company is undervalued.

Fortunately, that allows long-term investors to lock in a 3.2% dividend (almost double the average S&P 500 company) at its current $63 share price.

As long as the stores remain open, look for CVS to reach new all-time highs by the end of the year.

The $3 “Stock of the Year”

Picture the perfect stock for a moment.

What would it look like?

No doubt it would have hundreds of billions in revenue – more than tech giants like IBM, Facebook and Google.

It would probably be a leader in cutting-edge technology like smartphones, robotics, e-commerce and medical equipment.

It would have tens of thousands of unbreakable patents.

It would pay an enormous dividend.

It would be on the verge of dozens of blockbuster announcements that would send the stock higher and higher.

And most of all…

It would trade ultra-cheap – less than $3.

It seems crazy that such a stock exists.

But it does.

And you've likely never heard of it.

Why?

Because it trades under a secret name.

Seriously, it's true.

My colleague – stock-picking legend Alexander Green – just gave the most shocking live presentation regarding this “perfect stock.”

 He says this single stock alone could pay for your retirement.

Go here to see more for yourself now.

$3 EV Play No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$2 Biotech Stock

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only $2.

Enter your email address to receive this company’s name and ticker symbol for free.


Free Bonus E-Book: The Second Wave Why popular tech stocks could be in store for a 92% meltdown and the #1 investment billionaires are turning to now... from Morning Bullets. Privacy Policy

By submitting your email address, you give Stock Market Junkie permission to 1. deliver the report or research you're requesting to your email inbox, 2. send free ongoing updates via our independent financial email newsletter, and 3. share carefully selected marketing offers for product and services we think will interest you. Your privacy and security are paramount to us. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works